Tests used to detect Covid-19, blood infections, or other conditions and diseases will be regulated by the FDA after the agency Monday finalized a rule giving it authority over the diagnostics.
The Food and Drug Administration’s rule (RIN 0910-AI85) gives the agency explicit authority to regulate medical tests that come from a single laboratory, also known as lab-developed tests (LDTs), and label them as medical devices under the Federal Food, Drug, and Cosmetic Act.
The 528-page rule follows the debate on whether the agency should have oversight over the tests. The FDA previously exercised general enforcement discretion for ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.